Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury.

Zhao, Danyang; Yang, Lei; Han, Peng; Zhang, Haihui; Wang, Fanjun; Meng, Zhiyun; Gan, Hui; Wu, Zhuona; Sun, Wenzhong; Chen, Chuan; Dou, Guifang; Gu, Ruolan

Zhao, Danyang; Yang, Lei; Han, Peng; Zhang, Haihui; Wang, Fanjun; Meng, Zhiyun; Gan, Hui; Wu, Zhuona; Sun, Wenzhong; Chen, Chuan; Dou, Guifang; Gu, Ruolan.

Afiliación

Zhao D; School of Life Sciences, Hebei University, Baoding, China.
Yang L; Beijing Institute of Radiation Medicine, Beijing, China.
Han P; Beijing Institute of Radiation Medicine, Beijing, China.
Zhang H; Beijing Institute of Radiation Medicine, Beijing, China.
Wang F; Beijing Institute of Radiation Medicine, Beijing, China.
Meng Z; Beijing Institute of Radiation Medicine, Beijing, China.
Gan H; Beijing Institute of Radiation Medicine, Beijing, China.
Wu Z; Beijing Institute of Radiation Medicine, Beijing, China.
Sun W; Beijing Institute of Radiation Medicine, Beijing, China.
Chen C; Beijing Institute of Radiation Medicine, Beijing, China.
Dou G; School of Life Sciences, Hebei University, Baoding, China.
Gu R; Beijing Institute of Radiation Medicine, Beijing, China.

Front Pharmacol ; 14: 1171293, 2023.

Article en En | MEDLINE | ID: mdl-37274104

Palabras clave

ARS; DR5; TRAIL; apoptosis antagonist; radiation damage effect

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google